Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $79.05 | Total: $395.25 |
| 1 | 10 | $66.96 | Total: $669.60 |
| 1 | 25 | $56.73 | Total: $1,418.25 |
| 1 | 50 | $48.36 | Total: $2,418.00 |
| 1 | 100 | $41.85 | Total: $4,185.00 |
Overview
EHP-101 (VCE-004.8) is a specific dual agonist of PPAR? and CB2 receptor with potent anti-inflammatory activity. EHP-101 attenuates adipogenesis and prevents diet-induced obesity.
Chemical Properties
| Molecular Formula | C28H35NO3 |
| Molecular Weight | 433.58 |
| CAS Numbers | 1818428-24-8 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCCCCC1=C(NCc2ccccc2)C(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Navarrete C, et al. Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative implications for multiple sclerosis therapy. J Neuroinflammation. 2018 Mar 1;15[1] 64.